← Leaderboards
Jay A Levy
University Of California San Francisco
$23,476,333
Attributed
$23,476,333
Total exposure
17
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$23,476,333 · 17
By mechanism
U01$12,985,385 · 1
R01$6,417,473 · 3
R21$1,525,601 · 4
P01$943,514 · 1
R56$748,931 · 2
T32$742,552 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Ajay N Jain$7,260,163
- Edward L Murphy$11,879,629
- Susan Folkman$5,696,719
- Karen K Smith-McCune$2,725,446
- Elizabeth A. Holly$9,670,909
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsCellsAntiviral AgentsProceduresImmune ResponseDisease ProgressionGenesGene ExpressionLaboratoriesCd8-Positive T-LymphocytesAntiviral ResponseCd4 Positive T LymphocytesProtein PurificationHiv-1ResponsePathologic ProcessVirus ReplicationProteinsMediatingEvaluationProductionClinical ResearchImmuneImmune System
Grant awards (44)
Characterization of a New Anti-HIV Immune Protein$198,125
R21 · FY2018 · AI · contact PI
Characterization of a New Anti-HIV Immune Protein$237,750
R21 · FY2017 · AI · contact PI
HIV Cure with CCr5 (-) Human IPS Hematopoietic Stem Cells$697,712
R01 · FY2016 · AI · contact PI
HIV Cure with CCr5 (-) Human IPS Hematopoietic Stem Cells$697,354
R01 · FY2015 · AI · contact PI
HIV Cure with CCr5 (-) Human IPS Hematopoietic Stem Cells$613,068
R01 · FY2014 · AI · contact PI
HIV cure with CCR5 (-) human IPS hematopoietic stem cells$518,244
R56 · FY2012 · AI · contact PI
Protection from HIV Infection in Intravenous Drug Users$195,784
R21 · FY2011 · DA · contact PI
Role of Innate Immunity in Controlling HIV Infection$721,499
R01 · FY2010 · AI · contact PI
Protection from HIV Infection in Intravenous Drug Users$255,325
R21 · FY2010 · DA · contact PI
Role of Innate Immunity in Controlling HIV Infection$378,911
R01 · FY2009 · AI · contact PI
Role of Innate Immunity in Controlling HIV Infection$150,000
R01 · FY2009 · AI · contact PI
Role of Innate Immunity in Controlling HIV Infection$542,834
R01 · FY2008 · AI · contact PI
Project 3 - MBSR & the Immune System in Early HIV Infection$184,274
P01 · FY2008 · AT · contact PI
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR$11,529
P41 · FY2008 · RR · contact PI
Role of Innate Immunity in Controlling HIV Infection$230,687
R56 · FY2007 · AI · contact PI
Role of Innate Immunity in Controlling HIV Infection$192,500
R01 · FY2007 · AI · contact PI
Project 3 - MBSR & the Immune System in Early HIV Infection$177,946
P01 · FY2007 · AT · contact PI
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR$4,501
P41 · FY2007 · RR · contact PI
Immunologic & Virologic Features of Early HIV Infection$1,993,711
U01 · FY2006 · AI · contact PI
Role of Innate Immunity in Controlling HIV Infection$643,367
R01 · FY2006 · AI · contact PI
Project 3 - MBSR & the Immune System in Early HIV Infection$205,883
P01 · FY2006 · AT · contact PI
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR$18,931
P41 · FY2006 · RR · contact PI
Immunologic &Virologic Features of Early HIV Infection$1,993,711
U01 · FY2005 · AI
Role of Innate Immunity in Controlling HIV Infection$639,750
R01 · FY2005 · AI
Project 3 - MBSR &the Immune System in Early HIV Infection$196,877
P01 · FY2005 · AT
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR$26,978
P41 · FY2005 · RR
Immunologic &Virologic Features of Early HIV Infection$1,939,095
U01 · FY2004 · AI
Role of Innate Immunity in Controlling HIV Infection$621,203
R01 · FY2004 · AI
Project 3 - MBSR &the Immune System in Early HIV Infection$178,534
P01 · FY2004 · AT
UCSF AIDS RESEARCH TRAINING PROGRAM$127,714
T32 · FY2004 · AI
IDENTIFICATION OF CD8+ CELL ANTI HIV FACTOR$38,938
P41 · FY2004 · RR
Immunologic &Virologic Features of Early HIV Infection$1,850,423
U01 · FY2003 · AI
Role of Innate Immunity in Controlling HIV Infection$302,155
R01 · FY2003 · AI
UCSF AIDS RESEARCH TRAINING PROGRAM$123,282
T32 · FY2003 · AI
20Years of HIV Research: From Discovery to Understanding$12,000
R13 · FY2003 · AI
Immunologic &Virologic Features of Early HIV Infection$1,799,925
U01 · FY2002 · AI
UCSF AIDS RESEARCH TRAINING PROGRAM$113,212
T32 · FY2002 · AI
IMMUNOLOGIC &VIROLOGIC FEATURES OF EARLY HIV INFECTION$1,774,754
U01 · FY2001 · AI
Suppression of HIV replication by CD8+ cells$440,843
R21 · FY2001 · AI
UCSF AIDS RESEARCH TRAINING PROGRAM$195,220
T32 · FY2001 · AI
IMMUNOLOGIC &VIROLOGIC FEATURES OF EARLY HIV INFECTION$1,633,766
U01 · FY2000 · AI
ANIMAL MODEL FOR HIV VACCINE DEVELOPMENT$217,120
R01 · FY2000 · RR
SUPPRESSION OF HIV REPLICATION BY CD8+ CELLS$197,774
R21 · FY2000 · AI
UCSF AIDS RESEARCH TRAINING PROGRAM$183,124
T32 · FY2000 · AI